Ted Love, M.D.
Board Member
Structure Therapeutics Inc. (GPCR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ted Love, M.D.
Ted Love, M.D. is recorded as Board Member at Structure Therapeutics Inc. (GPCR). Structure Therapeutics Inc. reported in an 8-K filed August 4, 2023 that Ted Love, M.D. was appointed Class III director, effective August 3, 2023.
“On August 3, 2023, the Board of Directors (the "Board") of Structure Therapeutics Inc. (the "Company"), upon recommendation of the Nominating and Corporate Governance Committee of the Board (the "Governance Committee"), appointed Ted Love, M.D. to the Board, effective immediately. Dr. Love will serve as a Class III director, with an initial term expiring at the Company's 2026 Annual Meeting of Shareholders, and as Chair of the Compensation Committee of the Board (the "Compensation Committee").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-08-03–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Structure Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Raymond Stevens CEO, Board Member
- Jun Yoon CFO
- Matthew Lang COO, General Counsel
- Yingli Ma CTO
- Angus Russell Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.